Related Experiment Video
Updated: May 3, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
13.9K
Neurological update: dementia.
1Cognitive Function Clinic, Walton Centre for Neurology and Neurosurgery, Lower Lane, Fazakerley, Liverpool, L9 7LJ, UK, a.larner@thewaltoncentre.nhs.uk.
Journal of Neurology
|February 7, 2014
Summary
This review highlights recent advancements in understanding dementia disorders. Deeper insights into clinical and pathophysiological phenomena are crucial for developing effective treatments by 2025.
Area of Science:
- Neurology
- Neuroscience
- Clinical Medicine
Background:
- Dementia research is a high-priority area with significant public and political attention.
- A global initiative aims to find a cure or treatment for dementia by 2025.
- Understanding the complex clinical and pathophysiological aspects of dementia is essential.
Purpose of the Study:
- To review key findings and advancements in dementia research published in the Journal of Neurology in 2013.
- To consolidate current knowledge on the clinical and pathophysiological phenomena of dementia disorders.
- To provide a comprehensive overview of the state of dementia research.
Main Methods:
- Literature review of articles published in the Journal of Neurology in 2013.
- Synthesis of information on clinical presentations of dementia disorders.
- Analysis of pathophysiological mechanisms underlying dementia.
Main Results:
- The review covers a range of dementia disorders and their associated clinical features.
- Key pathophysiological pathways and molecular mechanisms are discussed.
- Recent research highlights progress in understanding disease progression and heterogeneity.
Conclusions:
- Continued in-depth research into the clinical and pathophysiological aspects of dementia is vital.
- The findings underscore the complexity of dementia disorders.
- Advancements reviewed provide a foundation for future therapeutic strategies and the 2025 treatment goal.
Related Concept Videos
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
01:30Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:28Disorders of the Nervous Tissue
3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35